ARTPred B.V. is a research driven medtech company in the field of reproductive health. Our vision is to fundamentally improve global fertility care by making our technologies available to every fertility patient. An important milestone has been realized; the development of world’s first microbiome based predictive test for IVF success, ReceptIVFity.
Sector of activity:
Business development, Marketing & Promotion, Patent and Intellectual Property (IP) Services, select_or_other, Gynecology / senology / Obstetrics, High Throughput Screening, Microbiology, Reproductive medicine